Xiaojie Xu
- Molecular Biology
- Radiology, Nuclear Medicine and Imaging top 10%
- Oncology
- Cancer Research
- Immunology
- Co-authors
- Lei KangWeibo CaiDawei JiangJonathan W. EngleRongfu WangNan HuoCuicui LiZachary T. Rosenkrans
- Topics
- Monoclonal and Polyclonal Antibodies Research (5 papers)Lymphoma Diagnosis and Treatment (5 papers)Radiopharmaceutical Chemistry and Applications (3 papers)
- Partner nations
- ChinaUnited StatesTaiwan
In The Last Decade
Xiaojie Xu
18 papers receiving 353 citations
Peers
Comparison fields: 5 of 59
- Molecular Biology 173
- Radiology, Nuclear Medicine and Imaging 131
- Oncology 123
- Cancer Research 72
- Immunology 52
Countries citing papers authored by Xiaojie Xu
This map shows the geographic impact of Xiaojie Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiaojie Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiaojie Xu more than expected).
Fields of papers citing papers by Xiaojie Xu
This network shows the impact of papers produced by Xiaojie Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiaojie Xu. The network helps show where Xiaojie Xu may publish in the future.
Co-authorship network of co-authors of Xiaojie Xu
This figure shows the co-authorship network connecting the top 25 collaborators of Xiaojie Xu. A scholar is included among the top collaborators of Xiaojie Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Xiaojie Xu. Xiaojie Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 13 | |
| 3 | 31 | |
| 4 | 19 | |
| 5 | 88 | |
| 6 | 21 | |
| 7 | 33 | |
| 8 | 32 | |
| 9 | 37 | |
| 10 | 22 | |
| 11 | 13 | |
| 12 | 15 | |
| 13 | 9 | |
| 14 | [PTEN loss correlates withthe clinical efficacy of lapatinib in HER2 positive metastatic breast cancer with trastuzumab-resistance]. | 4 |
| 15 | [FHL1 knockdown mediated by lentiviral shRNA promotes the growth of HeLa and HepG2 cells]. | 5 |
| 16 | 5 | |
| 17 | Evaluation of the effect of microRNA on hepatocellular carcinoma proliferation and metastasis by FDG small-animal PET | 1 |
| 18 | [Prokaryotic expression and purification of human GST-Cdc25C fusion protein and preliminary detection of its function]. | 1 |
| 19 | [Construction of human Egr-1 promoter and its response to ionizing radiation in tumor cells]. | 5 |
About Xiaojie Xu
Xiaojie Xu is a scholar working on Pathology and Forensic Medicine, Radiology, Nuclear Medicine and Imaging and Cancer Research, having authored 19 papers that have together received 354 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (5 papers), Lymphoma Diagnosis and Treatment (5 papers) and Radiopharmaceutical Chemistry and Applications (3 papers). The work is most often cited by research in Radiology, Nuclear Medicine and Imaging (131 citations), Cancer Research (72 citations) and Oncology (123 citations). Xiaojie Xu has collaborated with scholars based in China, United States and Taiwan. Frequent co-authors include Lei Kang, Weibo Cai, Dawei Jiang, Jonathan W. Engle, Rongfu Wang, Nan Huo, Cuicui Li, Zachary T. Rosenkrans, Hanxiao Liu and Todd E. Barnhart. Their work appears in journals such as Expert Systems with Applications, Advanced Science and Molecular Therapy.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.